Swing Trading

← Return to all swing-trade opportunities

RGEN — Oversold Bullish Reversal

Status: Invalidated

Scanner score: 20.0/100

Why this was flagged

RGEN was identified as a bullish technical setup based on the Oversold Bullish Reversal pattern. The scanner found a score of 20.0/100 using trend alignment, momentum, price action, volume, and risk-management rules. Monitor update: Latest daily-chart analysis no longer reports a bullish long setup.

Trade framework

Current price$164.68
Entry zone$164.68 – $166.38
Stop-loss / invalidation$160.19
Target 1$173.66
Target 2$178.14
Reward/risk2.00:1
Suggested holding windowAbout 2–8 trading days; reversal setups should work relatively quickly.
FoundSep 10, 2026 9:18 pm
Potential expirationSep 21, 2026 8:21 pm
Entry plan: Consider a limit order only within the displayed entry zone. If price does not enter that range, skip the trade rather than chasing it.

Position-sizing example

Reference entry$165.53
Planned risk per share$5.34
Example: $100 planned risk18 shares
Example: $250 planned risk46 shares

These examples use the distance between the reference entry and stop-loss. They do not account for commissions, slippage, taxes, overnight gaps, or your personal account size.

Exit plan

  1. Stop-loss: Exit if the stop-loss is reached. Do not move the stop farther away to avoid taking the planned loss.
  2. Target 1: Consider taking partial profit when Target 1 is reached and reducing risk on the remaining shares.
  3. Target 2 or trailing exit: Consider closing the remaining position at Target 2, or use a disciplined trailing stop only if the trend remains strong.
  4. Time exit: Reassess or close a trade that fails to progress within the suggested holding window.

Technical chart

Daily closing price with moving averages and planned trade levels. This chart is a screening aid, not a guarantee of future results.

$96.54$119.49$142.45$165.41$188.36Target 2 $178.14Target 1 $173.66Entry high $166.38Entry low $164.68Stop $160.19May 5, 2026Sep 11, 2026
CloseSMA 20EMA 20SMA 50SMA 200Entry zoneStop-lossTargets

$1,000 educational outcome examples

Example reference entry$165.53
Example fractional shares6.04
If Target 1 is reached$1,049.08 value (+4.9%)
If Target 2 is reached$1,076.19 value (+7.6%)
If the stop-loss is reached$967.75 value (-3.2%)

These examples use a $1,000 position and fractional shares at the midpoint of the entry zone. Actual results can differ because of market gaps, fills, spreads, commissions, taxes, slippage, and changing conditions.

Easy explanation for new investors

Why the scanner noticed this stock
The computer program found Repligen Corp, or RGEN, because it looks like it might start climbing again. The tool calls this an "Oversold Bullish Reversal." This simple phrase means the stock price dropped a lot recently. When a price falls hard, it is called oversold. This often happens when people panic and sell. The scanner noticed that the RSI, which tracks speed, is at 29.98. A score under 30 usually signals that selling pressure is very strong. The system also saw a specific candle pattern that hints at a turn. However, the overall score is only 20 out of 100. This low number tells us the setup is weak. Many other checks for strength did not pass. Think of it as a weak hint, not a loud shout.

What the price plan means
Right now, the stock trades near $164.68. The plan suggests looking at it between $164.68 and $166.38. If you follow a plan, you must have exit points. If the price drops below $160.19, the idea fails. You would stop watching it. If the price moves up, the first goal is $173.66. The second goal is $178.14. The plan aims for a reward of two times the risk. This means for every dollar you might lose if you are wrong, you might gain two dollars if you are right.

What could make the idea fail
The main problem is the low score of 20. Many other signals are missing. Also, the volume is normal, not high. Sometimes, a big move needs extra energy from many traders. Without that, the price might not move up. The RSI being low does not mean the price must go up. It just means it went down a lot.

Important reminder
This is not advice to buy or sell. Stocks can move in any direction. Always check facts yourself. This setup expires in September 2026. Do not guess. Use tools to learn how markets work.

Recent news context

This automated review is separate from the technical score. It summarizes recent related articles and does not predict price movement.

Overall context: Caution (Moderate confidence)

Recent news on Repligen Corp focuses on executive stock transactions. CEO Olivier Loeillot forfeited 2,842 shares in early September 2026 and sold 3,035 shares at $165.90, reducing his ownership to 48,369 shares. While one article source suggests a potential market opportunity, its content is unavailable for review. The technical setup indicates an oversold bullish reversal, but the recent insider selling and limited news coverage introduce uncertainty. Investors should monitor further developments regarding the company's fundamentals and leadership actions, as the available evidence does not provide a clear directional signal.

Potentially supportive context

  • Technical setup indicates an 'Oversold Bullish Reversal' with a technical score of 20.
  • CEO retained significant ownership, holding 48,369 shares after the recent transactions.

Risks and caution items

  • CEO sold 3,035 shares at $165.90 on September 4, 2026.
  • CEO forfeited 2,842 shares at $169.61 on September 3, 2026.
  • One referenced article summarizing potential market opportunity has no available text (NULL summary), limiting insight.
  • Recent news coverage is limited, with only two recent articles found, one of which is uninformative.

Latest reviewed article: Sep 9, 2026 5:54 pm

Recent related articles

Important: Some returned articles may describe competitors, industry conditions, or related companies. Open the source before relying on an article.

Scanner confirmations

  • RSI is near oversold territory with bullish candle confirmation.
Important: This is an automated educational screening result, not a buy recommendation. Confirm price, liquidity, earnings dates, news, and your own risk before entering any trade.
Scroll to Top